Closed-loop sensing capability instantly and automatically adjusts therapy while treating chronic painDUBLIN, April 26, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that the U.S. Food and Drug Administration (FDA) has approved the Inceptiv™ closed-loop rechargeable spinal cord stimulator (SCS) for the treatment of chronic pain. Inceptiv is the first Medtronic SCS device to offer a closed-loop feature that senses biological signals along the spinal ...

Medtronic (MDT) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.Over the past month, shares of this medical device company have returned -2.9%, compared to the Zacks S&P 500 composite's -3% change. During this period, the Zacks Medical - Products industry, which Medtronic falls in, has lost 2.7%. The key question now is: What could be the stock's future direction?A ...

While artificial intelligence may be useful for a variety of purposes – including asking silly questions we’re afraid to pose in real life – the ultimate end game for digital intelligence could be to advance the human condition, which brings us to medical AI stocks.When conducted in a controlled environment, AI can help accelerate productivity. It stands logically, then, that the innovation can help medical professionals better care for their patients. Indeed, the numbers reflect this trajectory.According t ...

The most recent trading session ended with Medtronic (MDT) standing at $80.57, reflecting a +1.37% shift from the previouse trading day's closing. This change outpaced the S&P 500's 0.87% gain on the day. Elsewhere, the Dow gained 0.67%, while the tech-heavy Nasdaq added 1.11%.Coming into today, shares of the medical device company had lost 4.33% in the past month. In that same time, the Medical sector lost 6.67%, while the S&P 500 lost 3.97%.Analysts and investors alike will be keeping a close eye on the p ...

Can this struggling healthcare specialist turn things around?Medtronic (MDT -0.21%) is a leading global medical device company with a massive presence that spans more than 150 countries. Its products assist patients with over 70 different health conditions. Investing in the stock is a potentially great way to gain exposure to the healthcare industry as a whole.Over the past five years, however, its shares have been a lackluster investment, falling by 8%. What should you do with Medtronic stock: buy, sell, o ...

According to a new survey from Medtronic and Morning Consult, nearly two-thirds of U.S. adults say they'd opt for a shorter, healthier life than a longer one with health issuesDUBLIN, April 17, 2024 /PRNewswire/ -- Americans overwhelmingly say that when they think about longevity, it's more than just living longer—it's about living their healthiest, best lives. While most want to live to 90—well past the average U.S. life expectancy of 77.5 years—nearly two-thirds (66%) would choose a shorter, healthier lif ...

Moussa81 Buying quality companies at reasonable prices remains a winning investment strategy in my opinion despite all the noise around high-flying Al names on the market today. What's even better is if those stocks pay you a decent yield for holding onto them, which makes natural price volatility easier to bear. This brings me to Medtronic (NYSE:MDT), which I last covered in August with a 'Buy' rating, noting its undervaluation, strong balance sheet, and positioning for international growth. Since my l ...

Altayb/E+ via Getty ImagesIntroduction Allow me to start this article by showing you a chart I have used quite a few times in the past few months. As we can see below, the market has a quite lofty valuation. The S&P 500 traded at 21x earnings going into this month. That's 1.3x its long-term standard deviation. In fact, it's the third-most expensive market since the early 1990s. Only the Dotcom and post-pandemic periods were more expensive. JPMorganThis does not mean that stocks are due for a massive sel ...

Medtronic (MDT) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.Shares of this medical device company have returned -2.6% over the past month versus the Zacks S&P 500 composite's +1.6% change. The Zacks Medical - Products industry, to which Medtronic belongs, has lost 3% over this period. Now the key question is: Where could the stock be headed in the near term?While media relea ...

Medtronic plc (MDT) recently presented positive clinical trial safety and efficacy results for Sphere-360 -- an investigational single-shot mapping and ablation catheter using pulsed field (PF) energy The catheter is intended for treatment of patients with paroxysmal atrial fibrillation (AFib).The European Heart Rhythm Association (EHRA) 2024 Annual Meeting featured a late-breaking clinical trial showcasing interim findings from the first-in-human Sphere-360 investigation.About Sphere-360 CatheterThe Sphere ...